GO
Loading...

Agios's new approach to cancer

Monday, 13 Jan 2014 | 11:00 AM ET

Agios CEO David Schenkein on a new approach to cancer, and the outlook for product approval, from the JPMorgan Health Care Conference in San Francisco.